STO Equity Snapshot

BIOA-B Weekly Equity Report

BioArctic AB (publ)

Interactive chart JSON snapshot
Latest Close 302.4 SEK 12 Jun 2026
1W Return -1.8% latest completed week
4W Return -6.2% short-term follow-through
12W Return -0.6% quarterly tape
Trend Breadth 80.8% 42 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
Company Brief

What the company does

BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of biological drugs, such as antibodies that address high unmet medical needs. The company's therapeutic areas encompass neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and other ALS diseases. In addition, it offers Lecanemab for intravenous treatment. Further, it is developing Lecanemab for Subcutaneous treatment, which is in registration stage; lecanemab, which is in phase 3 clinical trials for presymptomatic treatment; Exidavnemab, which is in phase 2 clinical trials; Lecanemab back-up, BAN2803, ND3014, …

Snapshot

What the weekly tape is saying

BIOA-B closed the latest completed week at 302.4 SEK. The 4-week return is -6.2% and the 12-week return is -0.6%. Trend Signal is active, Market Dynamics is -0.09. Setup signature: Balanced read with a 49/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend -4.1%
Volume 0.9x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 89 Persistence of active Trend Signal over the last year and current streak.
Momentum 35 Blend of 4-week and 12-week follow-through.
Dynamics 55 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 28 Relative leadership and short-term RS change.
Volume 40 Participation compared with the 13-week volume baseline.
Risk Control 46 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
315.4 SEK
Vs Trend Line
-4.1%
Fair Value
241.6 SEK
Vs Fair Value
25.1%
52W High
362.3 SEK
52W Low
173.5 SEK
Drawdown
-16.5%
Range Position
68.3%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -1.8%
4W -6.2%
12W -0.6%
26W -5.1%
52W 53.3%

Trend read

Active Streak
42 weeks
52W Active Weeks
42
52W Active Breadth
80.8%
Sector Scope
SE Healthcare
Sector Rank
86 of 158
Sector Percentile
45.9%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.09
4W MD Change
85.6%
Relative Strength
-3.46
4W RS Change
-144.3%
Expectation
Undecided
Probability
49.82%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
902.5K
13W Average
953.7K
52W Average
1.1M
Vs 13W
0.9x
Vs 52W
0.9x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.5%
52W Volatility
6.5%
Upside Weeks
28
Downside Weeks
24
Downside Breadth
46.2%
Avg Gain / Loss
5.5% / -4.1%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
STO
Country
SE
Sector
Healthcare
Industry
Biotechnology
Currency
SEK
Market Cap
30.7B

Opportunity signals

  • Trend Signal is active with a 42-week active streak.
  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 302.4 SEK -1.8% 315.4 SEK 241.6 SEK -0.09 -3.46 902.5K On
5 Jun 2026 308.0 SEK -12.6% 315.1 SEK 241.9 SEK -0.04 -1.44 950.1K On
29 May 2026 352.4 SEK 7.5% 313.6 SEK 242.2 SEK -0.14 12.41 1.0M On
22 May 2026 327.9 SEK 1.7% 311.6 SEK 242.0 SEK -0.38 5.12 1.7M On
15 May 2026 322.5 SEK 2.1% 310.3 SEK 242.0 SEK -0.65 7.80 641.9K On
8 May 2026 315.7 SEK -1.9% 309.4 SEK 241.9 SEK -0.64 5.04 890.3K On
1 May 2026 321.9 SEK 1.8% 308.5 SEK 241.8 SEK -0.59 8.20 863.1K On
24 Apr 2026 316.1 SEK -1.1% 308.2 SEK 241.6 SEK -0.67 5.41 718.5K On
17 Apr 2026 319.5 SEK -1.7% 307.1 SEK 241.2 SEK -0.70 4.33 2.2M On
10 Apr 2026 324.9 SEK -0.2% 306.0 SEK 240.7 SEK -0.95 9.19 643.1K On
3 Apr 2026 325.5 SEK 3.9% 304.2 SEK 240.1 SEK -1.14 15.47 547.6K On
27 Mar 2026 313.1 SEK 2.9% 302.9 SEK 239.6 SEK -1.23 15.89 668.9K On
20 Mar 2026 304.2 SEK 1.2% 302.5 SEK 239.2 SEK -1.19 13.35 647.8K On
13 Mar 2026 300.6 SEK 1.2% 300.4 SEK 238.8 SEK -0.70 6.88 800.9K On